Preclinical toxicology studies

Ended Definitive Contract Awarded Jul 1, 2011 Last action Jun 2, 2021

Contract number: HHSN261201100027C
Awardee: IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $2,752,435

Award facts

Opportunity: HHSN261 Solicitation number

Pre-Clinical Toxicology of Drugs Developed for Cancer and Other Diseases Award Notice · Posted Mar 30, 2010
Contract value 24% obligated: $2,752,435.22 Current, with exercised options

$11,526,862.22 Potential, with all options
Completion date 100% complete: Jun 30, 2017 Current and potential, with all options
NAICS code: 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing: Cost Plus Fixed Fee
Place of performance: Chicago, IL 60616, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Funding Only Action P00041 · Preclinical toxicology study of drugs developed for cancer and other diseases	-$2,239	Jun 3, 2021
Funding Only Action P00040	-$1,727	Mar 3, 2021
Funding Only Action P00039	-$11,950	Jul 14, 2020
Other Administrative Action P00038 · Period of performance 07/01/2011 - 06/30/2017	-$1	May 2, 2019
Funding Only Action 37	-$114,357	May 15, 2017
Other Administrative Action 36	$58,817	May 25, 2016
Other Administrative Action 35	$2,239	Dec 17, 2015
Other Administrative Action 34	$0	Oct 28, 2015
Funding Only Action 33	$5,053	Aug 13, 2015
Funding Only Action 32	$19,775	Jul 2, 2015
Supplemental Agreement for work within scope 31	$2,659	Apr 23, 2015
Other Administrative Action 30	$142,738	Mar 10, 2015
Funding Only Action 29	$63,551	Jan 7, 2015
Other Administrative Action 28	$2,073	Dec 4, 2014
Other Administrative Action 27	$878	Nov 26, 2014
Other Administrative Action 26	$159,792	Aug 21, 2014
Funding Only Action 25	$11,704	Aug 20, 2014
Other Administrative Action 24	$517,087	Aug 18, 2014
Other Administrative Action 23	$0	Jun 23, 2014
Other Administrative Action 22	$187,197	May 12, 2014
Other Administrative Action 21	$8,438	Mar 27, 2014
Funding Only Action 20	$40,108	Mar 25, 2014
Other Administrative Action 19	$0	Feb 4, 2014
Other Administrative Action 18	$0	Nov 25, 2013
Funding Only Action 17	$57,801	Sep 15, 2013
Other Administrative Action 16	$51,073	Jul 17, 2013
Other Administrative Action 15	$0	May 16, 2013
Funding Only Action 14	$321,482	May 7, 2013
Funding Only Action 13	$111,884	Mar 19, 2013
Other Administrative Action 12	$0	Feb 20, 2013
Funding Only Action 11	$342,945	Feb 8, 2013
Supplemental Agreement for work within scope 10	$0	Sep 25, 2012
Other Administrative Action 9 · Other functions restructure the contract from multiple award cost-reimbursement work assignment contract to a multiple award ID/IQ contract.	$0	Sep 24, 2012
Funding Only Action 8	$265,000	Jul 30, 2012
Exercise an Option 7 · Other functions preclinical toxicology studies of drugs developed for cancer and other diseases - exercising option 1, 07/01/2011 - 06/30/2013.	$64,238	Jun 26, 2012
Other Administrative Action 6 · Preclinical toxicology studies of drugs developed for cancer and other diseases - MOD processed to provide contractor with two revised hhsar clauses.	$0	May 24, 2012
Funding Only Action 5 · Other functions preclinical toxicology studies of drugs developed for cancer and other diseases - proposed WA 04, MOD 02.	$27,000	Apr 23, 2012
Funding Only Action 4 · Preclinical toxicology studies of drugs developed for cancer and other diseases - proposed WA 03 additional work.	$58,660	Mar 14, 2012
Funding Only Action 3	$57,906	Mar 2, 2012
Funding Only Action 2 · Other functions preclinical toxicology studies of drugs developed for cancer and other diseases - proposed WA 01 & WA 04 additional work.	$145,659	Jan 25, 2012
Funding Only Action 1	$106,952	Sep 15, 2011
Original award	$50,000	Jun 29, 2011

Show all 42

About this award

Written by GovTribe AI · May 31, 2026

The National Cancer Institute awarded a definitive contract to IIT Research Institute for preclinical toxicology studies of drugs developed for cancer and other diseases on July 1, 2011, with a ceiling value of $11,526,862.22 under cost-plus-fixed-fee pricing.

Place of performance is Chicago, IL. The contract runs through June 30, 2017. IIT Research Institute is a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, specializing in preclinical drug development services.

Quick answers

Who was awarded contract HHSN261201100027C?

HHSN261201100027C was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on July 1, 2011.

How much is contract HHSN261201100027C worth?

The government has obligated $2,752,435 on HHSN261201100027C. Its potential value, with all options, is $11,526,862.

Was contract HHSN261201100027C competed?

The extent of competition for HHSN261201100027C was full and open competition. The government received 9 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login